Related Experiment Video
Updated: Jul 18, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson's Disease
Salima Brillman1, Pravin Khemani2, Stuart H Isaacson3
1Parkinson's Disease and Movement Disorders Center of Silicon Valley, Palo Alto, CA, US.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|August 28, 2023
Summary
Transcutaneous afferent patterned stimulation (TAPS) significantly reduced action tremor in Parkinson's disease (PD) patients. This non-invasive therapy offers a promising new treatment option for improving daily activities in those with PD.
Area of Science:
- Neurology
- Biomedical Engineering
- Neurosurgery
Background:
- Parkinson's disease (PD) often causes action tremors, impacting daily life.
- Transcutaneous afferent patterned stimulation (TAPS) is a non-invasive neuromodulation technique targeting tremor-generating brain regions.
- Previous studies primarily focused on TAPS for essential tremor (ET); its efficacy in PD was less understood.
Purpose of the Study:
- To evaluate the effectiveness of TAPS in alleviating action tremors in patients diagnosed with Parkinson's disease.
- To assess TAPS's impact on objective tremor measurements and patient-reported functional outcomes.
Main Methods:
- A prospective, open-label study involved 40 PD patients with action tremors.
- Participants underwent four weeks of at-home TAPS, with telemedicine check-ins.
- Tremor power, MDS-UPDRS III, and BF-ADL scores were primary and secondary outcome measures.
Main Results:
- TAPS demonstrated a 64% median reduction in tremor power (p < 0.001), with 79% achieving ≥50% reduction.
- Significant improvements were observed in MDS-UPDRS III tremor ratings and BF-ADL scores.
- High percentages of patients (75-83%) and clinicians (78-83%) reported meaningful improvement.
Conclusions:
- TAPS provides clinically significant relief for action tremors in Parkinson's disease patients.
- The therapy is well-tolerated, with minor adverse events like skin irritation.
- TAPS represents a viable, non-invasive therapeutic option for managing PD-related tremors.
Related Concept Videos
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593

